Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria

Clinical trial NCT05843851 · UNKNOWN

Trial details

NCT number: NCT05843851
Sponsor: Cystinose Stiftung
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Cystinosis Primary Hyperoxaluria

Start date: 2022-03-15
Primary completion: 2025-12-31
Enrollment: 200000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.